Literature DB >> 26597080

Significant Improvements in the Practice Patterns of Adult Related Donor Care in US Transplantation Centers.

Chloe Anthias1, Bronwen E Shaw2, Deidre M Kiefer3, Jane L Liesveld4, Jean Yared5, Rammurti T Kamble6, Anita D'Souza2, Peiman Hematti7, Matthew D Seftel8, Maxim Norkin9, Zachariah DeFilipp10, Kimberly A Kasow11, Muneer H Abidi12, Bipin N Savani13, Nirali N Shah14, Paolo Anderlini15, Miguel A Diaz16, Adriana K Malone17, Joerg P Halter18, Hillard M Lazarus19, Brent R Logan20, Galen E Switzer21, Michael A Pulsipher22, Dennis L Confer23, Paul V O'Donnell24.   

Abstract

Recent investigations have found a higher incidence of adverse events associated with hematopoietic cell donation in related donors (RDs) who have morbidities that if present in an unrelated donor (UD) would preclude donation. In the UD setting, regulatory standards ensure independent assessment of donors, one of several crucial measures to safeguard donor health and safety. A survey conducted by the Center for International Blood and Marrow Transplant Research (CIBMTR) Donor Health and Safety Working Committee in 2007 reported a potential conflict of interest in >70% of US centers, where physicians had simultaneous responsibility for RDs and their recipients. Consequently, several international organizations have endeavored to improve practice through regulations and consensus recommendations. We hypothesized that the changes in the 2012 Foundation for the Accreditation of Cellular Therapy and the Joint Accreditation Committee-International Society for Cellular Therapy and European Society for Blood and Marrow Transplantation standards resulting from the CIBMTR study would have significantly impacted practice. Accordingly, we conducted a follow-up survey of US transplantation centers to assess practice changes since 2007, and to investigate additional areas where RD care was predicted to differ from UD care. A total of 73 centers (53%), performing 79% of RD transplantations in the United States, responded. Significant improvements were observed since the earlier survey; 62% centers now ensure separation of RD and recipient care (P < .0001). This study identifies several areas where RD management does not meet international donor care standards, however. Particular concerns include counseling and assessment of donors before HLA typing, with 61% centers first disclosing donor HLA results to an individual other than the donor, the use of unlicensed mobilization agents, and the absence of long-term donor follow-up. Recommendations for improvement are made.
Copyright © 2016 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Accreditation; Hematopoietic cell donation; Related donor

Mesh:

Year:  2015        PMID: 26597080      PMCID: PMC4760616          DOI: 10.1016/j.bbmt.2015.11.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  21 in total

1.  The consensus statement of the Amsterdam Forum on the Care of the Live Kidney Donor.

Authors: 
Journal:  Transplantation       Date:  2004-08-27       Impact factor: 4.939

2.  Managing a dual role--experiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children.

Authors:  S M van Walraven; L M Ball; H M Koopman; G E Switzer; C M H Ropes-de Jong; A de Jong; R G M Bredius; R M Egeler
Journal:  Psychooncology       Date:  2010-12-19       Impact factor: 3.894

3.  Evaluation of hematopoietic stem cell donors.

Authors:  Mary M Horowitz; Dennis L Confer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

4.  A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines.

Authors:  Mark L Barr; Jacques Belghiti; Federico G Villamil; Elizabeth A Pomfret; David S Sutherland; Rainer W Gruessner; Alan N Langnas; Francis L Delmonico
Journal:  Transplantation       Date:  2006-05-27       Impact factor: 4.939

5.  Family donor care management: principles and recommendations.

Authors:  S M van Walraven; G Nicoloso-de Faveri; U A I Axdorph-Nygell; K W Douglas; D A Jones; S J Lee; M Pulsipher; L Ritchie; J Halter; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2009-12-21       Impact factor: 5.483

6.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

7.  Practice patterns for evaluation, consent, and care of related donors and recipients at hematopoietic cell transplantation centers in the United States.

Authors:  Paul V O'Donnell; Tanya L Pedersen; Dennis L Confer; J Douglas Rizzo; Michael A Pulsipher; David Stroncek; Susan Leitman; Paolo Anderlini
Journal:  Blood       Date:  2010-03-12       Impact factor: 22.113

8.  Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry.

Authors:  Javier de la Rubia; Felipe de Arriba; Cristina Arbona; María J Pascual; Concha Zamora; Andrés Insunza; Dorleta Martínez; Carmen Paniagua; Miguel A Díaz; Miguel A Sanz
Journal:  Haematologica       Date:  2008-04-02       Impact factor: 9.941

9.  Severe events in donors after allogeneic hematopoietic stem cell donation.

Authors:  Joerg Halter; Yoshihisa Kodera; Alvaro Urbano Ispizua; Hildegard T Greinix; Norbert Schmitz; Geneviève Favre; Helen Baldomero; Dietger Niederwieser; Jane F Apperley; Alois Gratwohl
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

10.  Management of related donor care: a European survey.

Authors:  S Clare; A Mank; R Stone; M Davies; C Potting; J F Apperley
Journal:  Bone Marrow Transplant       Date:  2009-06-08       Impact factor: 5.483

View more
  5 in total

1.  Experiences and unmet needs of family members requested to donate haematopoietic stem cells to an ill relative: findings from a prospective multi-centre study.

Authors:  Nienke Zomerdijk; Jane Turner; Geoffrey R Hill; David Gottlieb
Journal:  Support Care Cancer       Date:  2020-05-18       Impact factor: 3.603

Review 2.  Sixty as the new forty: considerations on older related stem cell donors.

Authors:  P Anderlini
Journal:  Bone Marrow Transplant       Date:  2016-08-08       Impact factor: 5.483

3.  Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study.

Authors:  Matthew D Seftel; Pintip Chitphakdithai; John P Miller; Hati Kobusingye; Brent R Logan; Michael Linenberger; Andrew S Artz; Ann E Haight; David A Jacobsohn; Mark R Litzow; Margarida Magalhaes-Silverman; George B Selby; Madhuri Vusirikala; Mary M Horowitz; Galen E Switzer; Dennis L Confer; Bronwen E Shaw; Michael A Pulsipher
Journal:  Transplant Cell Ther       Date:  2021-01-15

4.  JACIE accreditation for blood and marrow transplantation: past, present and future directions of an international model for healthcare quality improvement.

Authors:  J A Snowden; E McGrath; R F Duarte; R Saccardi; K Orchard; N Worel; J Kuball; C Chabannon; M Mohty
Journal:  Bone Marrow Transplant       Date:  2017-03-27       Impact factor: 5.483

5.  Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Authors:  Michael A Pulsipher; Brent R Logan; Deidre M Kiefer; Pintip Chitphakdithai; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; O'Susan F Leitman; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Luke P Akard; Andrew S Artz; Edward D Ball; Ruthee-Lu Bayer; Carolyn Bigelow; Brian J Bolwell; E Randolph Broun; David C Delgado; Katharine Duckworth; Christopher C Dvorak; Theresa E Hahn; Ann E Haight; Parameswaran N Hari; Brandon M Hayes-Lattin; David A Jacobsohn; Ann A Jakubowski; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Michael Linenberger; Mark R Litzow; Walter Longo; Margarida Magalhaes-Silverman; John M McCarty; Joseph P McGuirk; Shahram Mori; Vinod Parameswaran; Vinod K Prasad; Scott D Rowley; Witold B Rybka; Indira Sahdev; Jeffrey R Schriber; George B Selby; Paul J Shaughnessy; Shalini Shenoy; Thomas Spitzer; William T Tse; Joseph P Uberti; Madhuri Vusirikala; Edmund K Waller; Daniel J Weisdorf; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Galen E Switzer; Dennis L Confer; Bronwen E Shaw
Journal:  Haematologica       Date:  2018-10-31       Impact factor: 9.941

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.